Inhibition of Platelet Aggregation Caused by Estrogen Treatment in Patients with Carcinoma of the Prostate

Platelet aggregation is increased in patients with carcinoma of the prostate treated with estrogens. Hence, these patients have a high incidence of cardiovascular and thromboembolic diseases. Platelet aggregation has been tested with the platelet aggregation test. It was inhibited by administration of 500 mg. acetylsalicylic acid twice daily. An aggregation inhibiting effect has been found in all 38 patients. To reduce the excess hazards of cardiovascular complications of estrogens in treating carcinoma of the prostate acetylsalicylic acid is recommended as an adjunct therapy.Estrogen therapy for prostatic carcinoma may lead to the development of cardiovascular complications, such as thromb…

Statistics of Urolithiasis

The data of 1000 stone patients, (1) in fig.1, acauired through the questionnaire “Harnstein-Statistik” (2), see (1), were transferred to three computer cards per patient. The questionnaire comprises 147 items relevant to urolith pathogenesis. A computer program makes the correlation of these 8 parameters possible: male, female, flexible age groups, stone components, stone types, diagnoses, electrolytes, and infections. Under stone specific data (I) the distribution of the 22 stone components which were considered (see table 1) is listed according to sex, the kind of stone release, stone localisation, and various frequency distributions (4). The correlation of stone components with 6 stone …

Management of vesicovaginal fistulas with peritoneal flap interposition.